Safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – A phase 1 trial with three doses

Alimentary Pharmacology and Therapeutics

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/29sofSn
via IFTTT